Navigation Links
Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
Date:6/13/2011

TOKYO, June 14, 2011 /PRNewswire/ -- Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST® cTnI-II (cardiac Troponin I) diagnostic test, clearing the way for its sale in the United States. The test is designed to be used with the PATHFAST analysis system, a unique, self-contained, bench-top chemi-luminescence immunoanalyzer that rapidly measures concentrations of emergency biomarkers from a single whole blood sample.

The PATHFAST cTnI-II test determines the quantity of cardiac troponin I, a protein that is integral to cardiac muscle contraction, which is elevated in the bloodstream after damage to the myocardium (the middle and thickest layer of the heart wall).(1),(2) Due to its absolute coronary specificity and high sensitivity, cardiac troponin I is considered the preferred biomarker for diagnosing cardiac muscle damage, particularly following a heart attack.

"We are pleased that the FDA has recognized the utility of the PATHFAST system for measuring levels of cardiac troponin I in whole blood, and are confident the test will be widely accepted in the U.S. market, in accordance with international guidelines," commented Dr. Toshihiko Yoshitomi, President and CEO of Mitsubishi Chemical Medience. "Today's news is also an important step in supporting our ongoing negotiations to secure a strategic distribution partnership to launch the PATHFAST product line in the U.S. by early 2012."  

The 510(k) clearance of the PATHFAST cTnI-II test completes the cardiovascular product line of the PATHFAST analysis system, which also includes tests to determine quantities of N-terminal pro brain natriuretic peptide (NT-proBNP), D-Dimer, myoglobin, creatinine kinase (CK)-MB, and high-sensitivity C-reactive protein (hsCRP). With its whole blood use capability, the PATHFAST system eliminates the need for centrifugation of the sp
'/>"/>

SOURCE Mitsubishi Chemical Medience Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anaphore Enters R&D Partnership with Mitsubishi Tanabe Pharma to Develop and Commercialize Novel Protein Pharmaceuticals for Autoimmune Disorders
2. Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
3. AMPAC Fine Chemicals Adds New Capabilities for Clinical Programs
4. Ampac Fine Chemicals President Aslam Malik Joins SOCMAs Board of Governors; Industry Veteran Adds Significant Experience to Board
5. FDA Approves Pediatric Use of Chemical Poisoning Treatment
6. Dr. Harry J. Guttman, Esq. Invited Speaker at 2010 Central Regional Meeting of the American Chemical Society
7. Multiple Chemical Sensitivities Are Real
8. ChemImages Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development
9. AMPAC Fine Chemicals Partners With Inabata & Co., Ltd. of Japan
10. New ionator EXP(TM) and ionator HOM(TM) Kill Swine Flu Without Use of Chemicals
11. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 ... to drive bioinformatics market in Germany ... recently released TechSci Research report, " Germany Bioinformatics Market ... Germany is projected to register a ... expected to witness tremendous growth on account of rising ...
(Date:7/6/2015)... -- Hologic, Inc. (NASDAQ: HOLX ) announced today ... for the third quarter of fiscal 2015 on Wednesday, ... with the release, management will host a conference call ... Interested participants may listen to the call by dialing ... or 719-325-4804 (for international callers) and referencing access code ...
(Date:7/6/2015)... July 6, 2015 Moerae Matrix, a ... therapeutics that target inflammation and fibrosis, today announced ... PhD, as Chief Medical Officer. ... strategy and programs, which include a pipeline of ... fibrotic conditions.  Bill is an accomplished strategist and ...
Breaking Medicine Technology:Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2
... Therapeutics, Inc. (Nasdaq: OREX ) today announced the ... consisted of one share of common stock and a warrant ... to the public of $1.45 per share of common stock ... stock, which together comprised the purchase price of $15.94 per ...
... organizations, community leaders, health care professionals, and people of ... today urged Express Scripts to get back to the ... access to pharmacy services for hundreds of millions of ... put the people of our communities at the forefront ...
Cached Medicine Technology:Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock 2Over 130 Community Leaders and Organizations Across the Nation Urge Express Scripts To Reach Agreement With Walgreens 2
(Date:7/6/2015)... , ... July 06, 2015 , ... Shortly after opening ... , the leading network of doctors working on a lien basis. Dr. Lim ... Liens. , The daughter of two Cambodian refugees, Dr. Lim suffered with back pain ...
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to ... yet there is a large gap between the unmet health priorities in the ... health outcomes and reduce unnecessary or ineffective treatments or procedures. , This milestone ...
(Date:7/6/2015)... ... , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value of ... CAGR of over 3.2 percent in the years to come to hit the USD ... by an anticipated launch of a number of promising pipeline candidates and an increase ...
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the new ... ADVOCATE is leading the transition. ADVOCATE, the only 100% radiology, revenue cycle management ... Tips for ICD-10. The ten tips are timely and relevant guidelines to help ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... prevention in southern California, has partnered with Woodbridge Walk-In Urgent Care to offer ... stroke and other serious medical conditions. Screenings are affordable and accurate and run ...
Breaking Medicine News(10 mins):Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2
... News) -- Eating fruits and vegetables may reduce the risk ... Austrailian researchers examined the diets of 918 colorectal cancer patients ... found that consumption of certain vegetables and fruits were associated ... distal colon -- that is, the upper and lower portions ...
... AMRI (NASDAQ: AMRI) today announced the receipt of a ... its Burlington, Massachusetts aseptic finish-and-fill facility, acquired in June ... a August 2010 warning letter and a June 2011 ... AMRI, once fully implemented, should adequately address the observations ...
... are likely to change their preferences for receiving emergency ... new findings. The study, which will be ... Amsterdam today (26 September 2011), suggests that different factors ... this will often go unnoticed by their healthcare provider. ...
... and face-to-face therapy sessions for couples improve the sex ... is the finding of a new study published early ... the American Cancer Society. The results suggest that couples ... beyond those experienced from medications such as erectile dysfunction ...
... cancer survivors and their partners experience improved sexual satisfaction ... The University of Texas MD Anderson Cancer Center. The ... , a journal of the American Cancer Society, revealed ... equally effective in improving sexual outcomes. Couples on a ...
... Sweden: Results from the longest-running trial comparing tamoxifen ... letrozole has withstood the test of time and ... the risk of death in post-menopausal women with ... Gelber told delegates at the 2011 European Multidisciplinary ...
Cached Medicine News:Health News:Broccoli, Cabbage, Other Veggies May Protect Against Colon Cancer 2Health News:Study shows decisions over life-sustaining treatment are likely to change 2Health News:Couples counseling helps improve the sex lives of prostate cancer survivors and their spouses 2Health News:Couples counseling improves sexual intimacy after prostate treatment 2Health News:Couples counseling improves sexual intimacy after prostate treatment 3Health News:Couples counseling improves sexual intimacy after prostate treatment 4Health News:Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years 2Health News:Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years 3Health News:Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years 4
Anti-Gliadin IgG & IgA (Ab) EIA Gastrointestinal Markers 027-GD77 Celiac Disease Food Allergy...
... OCTEIA 25-Hydroxy Vitamin D kit is an ... and other hydroxylated metabolites in serum or ... with biotin labelled 25-OH D. The diluted ... are coated with a highly specific sheep ...
... principal hormone responsible for the control of glucose ... of the islets of Langerhans as the precursor, ... insulin. Both are secreted in equimolar amounts ... molecule is comprised of two polypeptide chains, the ...
... binding Proetin (RBP) is small (21kD) transport ... with pre-albumin in blood but loses its ... deliverd to the target cells. The free,RBP ... glomerulus and catabolized in the,renal tubules after ...
Medicine Products: